Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study
{{output}}
Background: Myocardial infarction (MI) is an adverse event potentially associated with capecitabine treatment, potentially impacting the continuation of cancer therapy. However, data on its incidence remain limited. ... ...
